Literature DB >> 24818319

St. Jude Trifecta versus Carpentier-Edwards Perimount Magna valves for the treatment of aortic stenosis: comparison of early Doppler-echocardiography and hemodynamic performance.

Giovanni Minardi, Amedeo Pergolini, Giordano Zampi, Giovanni Pulignano, Gaetano Pero, Fabio Sbaraglia, Paolo Giuseppe Pino, Giovanni Cioffi, Francesco Musumeci.   

Abstract

OBJECTIVE: Aim of this study was to compare the hemodynamic profiles of 2 aortic valve bioprostheses: the Carpentier Edwards Perimount Magna (CEPM) valve and the Trifecta valve.
METHODS: 100 patients who underwent AVR for severe symptomatic AS between September 2011 and October 2012 were analyzed by means of standard trans-thoracic Doppler-echocardiography.
RESULTS: Mean and peak gradients were significantly lower for the 21 mm Trifecta vs CEPM (11 +/- 4 vs 15 +/- 4 mmHg, and 20 +/- 6 vs 26 +/- 7 mmHg, respectively; all p < 0.05) and the 23 mm Trifecta vs CEPM (8 +/- 2 vs 14 +/- 4 mmHg, and 17 +/- 6 vs 25 +/- 9 mmHg; all p < 0.05). Effective orifice area tended to be slightly higher for the Trifecta valve.
CONCLUSION: The new bioprosthetic valve Trifecta has an excellent hemodynamic profile, and lower trans-prosthesic gradients when compared to CEPM valve.

Entities:  

Mesh:

Year:  2013        PMID: 24818319     DOI: 10.4081/monaldi.2013.74

Source DB:  PubMed          Journal:  Monaldi Arch Chest Dis        ISSN: 1122-0643


  4 in total

1.  Clinical outcome and hemodynamic performance of St. Jude Trifecta aortic prosthesis: short-term follow-up and risk factors analysis.

Authors:  Paolo Nardi; Calogera Pisano; Fabio Bertoldo; Sara Rita Vacirca; Monica Greci; Carlo Bassano; Antonio Scafuri; Antonio Pellegrino; Giovanni Ruvolo
Journal:  J Thorac Dis       Date:  2019-04       Impact factor: 2.895

2.  The Prognostic Significance of Patient-Prosthesis Mismatch after Aortic Valve Replacement.

Authors:  Paolo Nardi; Marco Russo; Guglielmo Saitto; Giovanni Ruvolo
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2018-06-05

3.  Short-term outcomes of aortic valve neocuspidization for various aortic valve diseases.

Authors:  Gregory Khatchatourov; Mathieu van Steenberghe; Doris Goy; Mathieu Potin; Javier Orrit; François Perret; Nicolas Murith; Jean-Jacques Goy
Journal:  JTCVS Open       Date:  2021-08-26

4.  St. Jude Medical Trifecta aortic valve: results from a prospective regional multicentre registry.

Authors:  Giovanni Mariscalco; Silvia Mariani; Samuele Bichi; Andrea Biondi; Andrea Blasio; Paolo Borsani; Fabrizio Corti; Benedetta De Chiara; Riccardo Gherli; Cristian Leva; Claudio Francesco Russo; Giordano Tasca; Paolo Vanelli; Ottavio Alfieri; Carlo Antona; Germano Di Credico; Giampiero Esposito; Amando Gamba; Luigi Martinelli; Lorenzo Menicanti; Giovanni Paolini; Cesare Beghi
Journal:  J Cardiothorac Surg       Date:  2015-11-20       Impact factor: 1.637

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.